Yaping Qin

Dendritic Cell Targeting Peptide-Based Nanovaccines for Enhanced Cancer Immunotherapy.

Yanfeng Gao, Y. Qi, Wenpeng Cao, 2019, ACS applied bio materials.

Primary resistance to first- and second-generation ALK inhibitors in a non-small cell lung cancer patient with coexisting ALK rearrangement and an ALK F1174L-cis-S1189C de novo mutation: A case report

Jiuzhou Zhao, Yongjun Guo, Xiao Zhang, 2022, Frontiers in Pharmacology.

Missense Variant of Endoplasmic Reticulum Region of WFS1 Gene Causes Autosomal Dominant Hearing Loss without Syndromic Phenotype

Hongen Xu, Wenxue Tang, Chang Yu, 2021, BioMed research international.

Case Report: A Case Report of a Histological Transformation of ALK-Rearranged Adenocarcinoma With High Expression of PD-L1 to Squamous Cell Carcinoma After Treatment With Alectinib

Jingli Ren, Hongen Xu, Yan Zhang, 2021, Pathology & Oncology Research.

Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans

Jianbo Liu, Yaohe Wang, Hongen Xu, 2021, Scientific reports.

Dynamics of binding ability prediction between spike protein and human ACE2 reveals the adaptive strategy of SARS-CoV-2 in humans

Jianbo Liu, Yaohe Wang, Hongen Xu, 2020, Scientific Reports.

The design of high affinity human PD-1 mutants by using molecular dynamics simulations (MD)

Yanfeng Gao, Jiangfeng Du, Wenjie Zhai, 2018, Cell Communication and Signaling.